Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis

Phase 3 Recruiting 231 enrolled Immunovant Sciences GmbH

RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of the study is to assess the efficacy, safety and tolerability of IMVT-1402 in adult participants with mild to severe generalized myasthenia gravis.

Timeline

Start: 2025-05-27
Primary completion: 2027-12
Completion: 2028-12

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	IMVT-1402	Unknown	—	Subcutaneous

Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis

Summary

Timeline

Drugs

Indications